Bafna Pharmaceuticals Limited (NSE:BAFNAPH)

Accolade Revenue

In the fiscal year ending March 31, 2025, Bafna Pharmaceuticals had annual revenue of 1.46B INR, down -4.33%. Bafna Pharmaceuticals had revenue of 390.60M in the quarter ending March 31, 2025, a decrease of -5.65%.

• Revenue: 1.46B
• Revenue Growth: -4.33%
• P/S Ratio: 1.39
• Revenue / Employee: 4.02M
• Employees: 363
• Market Cap: 2.03B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	1.46B	-66.09M	-4.33%
Mar 31, 2024	1.52B	371.16M	32.18%
Mar 31, 2023	1.15B	302.10M	35.48%
Mar 31, 2022	851.40M	139.22M	19.55%
Mar 31, 2021	712.18M	287.45M	67.68%